Given the increasing prevalence of chronic diseases and requirement for emergency medical interventions, there is an evident surge in the demand for wearable devices that allow safe and convenient administration of drugs at home-care settings
Roots Analysis has announced the addition of “Wearable Injectors Market, 2023-2035” report to its list of offerings.
The report features an extensive study on the extensive study of the current landscape and the likely future potential of wearable injectors market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:
§ A preface providing an introduction to the full report, Wearable Injectors Market, 2023-2035 (7th Edition).
§ An outline of the systematic research methodology adopted to conduct the study on wearable injectors market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
§ An overview of economic factors that impact the overall large volume wearable injectors market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
§ An executive summary of the insights captured during our research, offering a high-level view on the current state of wearable injectors and their likely evolution in the short to mid and long term.
§ A brief introduction to drug delivery devices, along with information on conventional parenteral drug delivery devices. It also highlights the key driving factors, need for improving medication adherence and different types of self-administration devices. Further, the chapter concludes with a discussion on regulatory considerations for these devices and future perspectives.
§ A detailed assessment of the overall market landscape of wearable injectors for the delivery of non-insulin drugs, based on several relevant parameters, including status of development (under development and commercialized), type of device (patch pumps / on body injectors and wearable infusion pumps), usability (disposable and reusable with disposable components), type of dose (basal and bolus), type of drug container (cartridges, vials, syringes and mini-bag systems), mode of drug filling (preloaded and manually loaded), container volume (mL), route of administration (subcutaneous, intravenous, intradermal and intramuscular), mode of injection (needles, cannulas and catheters), mechanism of action, type of technology, availability of connectivity feature, type of compatible drug (biologics, small molecules and others), compatibility with high viscosity drugs and therapeutic areas. In addition, the chapter presents the market landscape of companies manufacturing large volume wearable injectors for non-insulin drug delivery, including information on their year of establishment, company size (in terms of number of employees), and location of headquarters.
§ An overview of the current market landscape of wearable injection device and drug combinations for the delivery of non-insulin drugs, based on several relevant parameters, including status of development (under development, NDA/FDA accepted and commercialized), type of device (patch pumps / on body injectors and wearable infusion pumps), usability (disposable and reusable with disposable components), type of dose (basal and bolus), type of drug container (cartridges, drug reservoirs and vials), mode of drug filling (preloaded), container volume (mL), route of administration (subcutaneous, intravenous and others), mode of injection (needles and cannulas), type of compatible drug (biologics and small molecules), mechanism of action / driving force, type of technology and therapeutic area. Additionally, the chapter presents the market landscape of companies manufacturing drug-device combinations for non-insulin drug delivery, including information on their year of establishment, company size (in terms of number of employees), and location of headquarters.
§ A detailed assessment of the overall market landscape of wearable injectors for the delivery of insulin drugs, based on several relevant parameters, including status of development (under development and commercialized), type of device (patch pumps / injectors and infusion pumps / injectors), usability (disposable and reusable with disposable components), type of dose (basal and bolus), mode of drug filling (preloaded and manually loaded), container volume (mL), type of diabetes (type I and type II), type of combination insulin, period of use (days), type of device control feature (smartphone control, remote control and inbuilt control), availability of interoperable devices, availability of continuous glucose monitoring (CGM) / blood glucose meters (BGM) system, availability of automatic insulin delivery (AID) / artificial pancreas, type of automated insulin delivery feature (AID), availability of connectivity feature and waterproof capabilities. In addition, the chapter presents the market landscape of companies manufacturing large volume wearable injectors for insulin delivery, including information on their year of establishment, company size (in terms of number of employees), and location of headquarters.
§ A detailed product competitiveness analysis of various wearable injectors based on several relevant parameters, such as company strength (based on the experience of the company), product competitiveness (based on type of device, type of dose, container volume, usability, status of development, mode of injection, route of administration, type of drug container, type of drug compatibility, mode of drug filling, availability of connectivity feature, availability of CGM / BGM systems and waterproof capabilities) and company size (based on employee count of the product manufacturer).
§ Elaborate profiles of the prominent companies developing wearable injectors; each company profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments, and an informed future outlook.
§ A list of tabulated profiles of wearable drug device combination products featuring drug specifications, mechanism of action, current status of development, dosage frequency and information on sales (if available).
§ An in-dept analysis of the partnerships that have been inked by the stakeholders in the wearable injectors market, during the period 2015 and 2023 based on several relevant parameters, including year of partnership, type of partnership, type of partner, type of device, most active players (in terms of number of partnerships), most active players (in terms of type of partnership) and geography.
§ A detailed analysis of the key acquisition targets, taking into consideration the historical trend of the acquisition activity of the players that have acquired other firms, since 2000. It offers a means for other industry stakeholders to identify potential acquisition targets.
§ A list of patents that have been filed / granted related to wearable injectors over the last decade. Further, it highlights analysis of patents across several relevant parameters, such as type of patent (granted patents, patent applications and others), patent publication year, jurisdiction, CPC symbol, type of organization (industry and non-industry players), emerging focus area and most active players (based on the number of patents). Additionally, the chapter includes patent benchmarking analysis and insightful patent valuation analysis, highlighting the leading patents (in terms of number of citations).
§ A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with wearable injectors in the near future, identified on the basis of an in-depth analysis of potential candidates (marketed drugs and clinical-stage drugs), taking into consideration multiple parameters, such as type of drug molecule, phase of development, indication, dosing frequency, type of therapy, method of administration and route of administration.
§ A detailed analysis of completed, ongoing and planned clinical trials related to wearable injectors based on several relevant parameters, such as trial recruitment status, trial registration year, trial phase, study design, type of sponsor / collaborator, leading players (based on the number of registered trials), key focus area, therapeutic area, and geography.
§ A detailed analysis of funding and investments made in the companies engaged in this domain, during the period 2014 and 2023, including instances of seed financing, venture capital, capital raised from IPOs, secondary offerings, grants / awards, other equity and debt financing. Further, these instances have been analyzed based on various relevant parameters, such as year of funding, amount invested by year, type of funding, type of device, target disease indication, most active players (in terms of number of funding instances and amount invested), leading investors (in terms of number of funding instances) and geography.
§ A case study on the role of contract manufacturing organizations in the overall manufacturing process / supply chain of wearable injectors, featuring details on the services offered by contract service providers for the manufacturing of various device components (primary containers), infusion sets, adhesives, closures, and injection moldings.
§ A discussion on the various guidelines established by regulatory bodies for medical device approvals across North America (US, Canada and Mexico), Europe (UK, France, Germany, Italy, Spain and rest of Europe), Asia-Pacific and rest of the world (Australia, Brazil, China, India, Israel, Japan, New Zealand, Singapore, South Africa, South Korea, Taiwan, and Thailand). The market report also features an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
§ An in-depth analysis of the factors that can impact the growth of large volume wearable injectors market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
§ A detailed discussion on the future opportunities of wearable injectors for large volume drug delivery. It also highlights the key parameters and trends that are likely to influence the future of this market, under a detailed SWOT framework.
§ One of the key objectives of the market report was to estimate the existing market size and potential future growth of wearable injectors market over the coming years. Based on parameters, such as the number of commercialized devices, number of devices under development, price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the wearable injectors for delivery of non-insulin drugs market over the forecast period 2023-2035. The report also features the likely distribution of the current and the forecasted opportunity across various segments, such as type of device (patch pump / injector and infusion pump / injector), usability (disposable and reusable), therapeutic area (autoimmune disorders, cardiovascular disorders, metabolic disorders neurological disorders, oncological disorders and other disorders) and key geographical regions (North America, Europe, Asia, Latin America, and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base and optimistic scenarios, which represent different tracks of the industry’s evolution.
§ In Addition to this, report also provides a detailed market forecast analysis in order to estimate the existing market size and future opportunity for wearable injectors delivering insulin drugs over the coming years. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of device (patch pump / injector and infusion pump / injector), usability (disposable and reusable) and key geographical regions (North America, Europe, Asia, Latin America, and Middle East and North Africa).
By 2035, financial opportunity within the wearable injectors market has been analyzed across the following segments:
§ Type of Device
- Patch Pumps / Injectors
- Infusion Pumps / Injectors
§ Usability
- Disposable
- Reusable
§ Therapeutic Area
- Autoimmune Disorders
- Cardiovascular Disorders
- Metabolic Disorders
- Neurological Disorders
- Oncological Disorders
- Other Disorders
§ Key Geographical Regions
- North America
- Europe
- Asia
- Latin America
- Middle East and North Africa
Key Companies covered in the report
§ CCBio
§ CeQur
§ Debiotech
§ Elcam Drug Delivery Devices
§ Eli Lilly
§ Enable Injections
§ Gerresheimer
§ Insulet
§ Medtronic
§ Medtrum Technologies
§ Pharmasense
§ Roche
§ Sonceboz
§ SOOIL Development
§ Weibel CDS
§ West Pharmaceuticals
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/large-volume-wearable-injectors/238.html
Learn from experts: do you know about these emerging industry trends?
Single-use Bioreactor: An Indispensable Component for Biopharmaceutical Manufacturing
Bacteriophage Therapy – A Revolutionary Approach Towards Multi-Resistant Bacteria
Top 5 Companies Developing Tangential Flow Filtration Systems Used in Biologics Industry
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#WearableInjectorsMarket#WearableInjectorsMarketSize#LargeVolumeWearableInjectors#wearableinjectors#onbodyinjectors